Viatris marked 25 years of advancing cardiovascular health in Vietnam

Core Insights - Cardiovascular disease is the leading cause of death globally, with over 75% of deaths occurring in low- and middle-income countries, including Vietnam [1] - Approximately 30% of Vietnamese adults suffer from dyslipidemia, a significant risk factor for atherosclerotic cardiovascular disease [1] - Statins, particularly high-intensity statins like atorvastatin, are crucial in reducing the risk of heart attacks, strokes, and cardiovascular deaths [2] Company Initiatives - Viatris has organized scientific events to reaffirm its commitment to addressing cardiovascular challenges and improving public health in Vietnam [4] - A significant event was the conference titled "Atorvastatin: 25 Years Advancing Cardiovascular Health," which attracted over 400 healthcare professionals [5] - Viatris emphasizes community outreach through initiatives like the "Don't Miss A Beat" seminar and participation in running events to promote cardiovascular health [8][10] Scientific Contributions - Atorvastatin has been recognized for its effectiveness in preventing cardiovascular events across diverse patient populations, supported by extensive clinical evidence [6] - The company continues to leverage its scientific expertise and diverse medicine portfolio to improve access to high-quality medicines for Vietnamese patients [11][12] Commitment to Health - Viatris aims to raise awareness about cardiovascular health and is committed to partnering with healthcare professionals for a healthier Vietnam [10] - The company’s mission is to empower healthier living by providing access to high-quality medicines for approximately 1 billion patients annually [12]